MiRNA-26b inhibits proliferation by targeting PTGS2 in breast cancer

Cancer Cell International

Volumn 13, Issue 1, 2013, Pages

  Li, Jia ^a   Kong, Xiangjie ^a   Zhang, Junfeng ^a   Luo, Qifeng ^a   Li, Xiaoyu ^a   Fang, Lin ^a  

^a TENTH PEOPLE S HOSPITAL OF TONGJI UNIVERSITY   (China)

Author keywords

Breast cancer; MiR 26b; Proliferation; PTGS2

Indexed keywords

LUCIFERASE; MESSENGER RNA; MICRORNA; PROSTAGLANDIN ENDOPEROXIDE SYNTHASE 2; PROSTAGLANDIN SYNTHASE; SMALL INTERFERING RNA; TETRAZOLIUM; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL GROWTH; DOWN REGULATION; DRUG TARGETING; HUMAN; HUMAN CELL; PATHOGENESIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

EID: 84873047493     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-13-7     Document Type: Article

References (26)

1. He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nature Rev Genet 2004, 5:522-531. 10.1038/nrg1379, 15211354.
2. Guttilla IK, White BA. Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells. J Biol Chem 2009, 284:23204-23216. 10.1074/jbc.M109.031427, 2749094, 19574223.
3. Hsu PY, Deatherage DE, Rodriguez BA, Liyanarachchi S, Weng YI, Zuo T, Liu J, Cheng AS, Huang TH. Xenoestrogen-induced epigenetic repression of microRNA-9-3 in breast epithelial cells. Cancer Res 2009, 69:5936-5945. 10.1158/0008-5472.CAN-08-4914, 2855843, 19549897.
4. Wu HL, Zhu SM, Mo YY. Suppression of cell growth and invasion by miR-205 in breast cancer. Cell Res 2009, 19:439-448. 10.1038/cr.2009.18, 2664859, 19238171.
5. Pan YZ, Morris ME, Yu AM. MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells. Mol Pharmacol 2009, 75:1374-1379. 10.1124/mol.108.054163, 2684886, 19270061.
6. Liang Z, Wu H, Xia J, Li Y, Zhang Y, Huang K, Wagar N, Yoon Y, Cho HT, Scala S, Shim H. Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein1. Biochem Pharmacol 2010, 79:817-824. 10.1016/j.bcp.2009.10.017, 2880168, 19883630.
7. Ji J, Shi J, Budhu A, Yu Z, Forgues M, Roessler S, Ambs S, Chen Y, Meltzer PS, Croce CM, Qin LX, Man K, Lo CM, Lee J, Ng IO, Fan J, Tang ZY, Sun HC, Wang XW. MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med 2009, 361:1437-1447. 10.1056/NEJMoa0901282, 2786938, 19812400.
8. Ji Y, He Y, Liu L, Zhong X. MiRNA-26b regulates the expression of cyclooxygenase-2 in desferrioxamine-treated CNE cells. FEBS Lett 2010, 584:961-967. 10.1016/j.febslet.2010.01.036, 20100477.
9. Gao W, Shen H, Liu L, Xu J, Xu J, Shu Y. MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis. J Cancer Res Clin Oncol 2011, 137:557-566. 10.1007/s00432-010-0918-4, 20508945.
10. Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP, Wei WI. Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res 2008, 14:2588-2592. 10.1158/1078-0432.CCR-07-0666, 18451220.
11. Liu XX, Li XJ, Zhang B, Liang YJ, Zhou CX, Cao DX, He M, Chen GQ, He JR, Zhao Q. MicroRNA-26b is underexpressed in human breast cancer and induces cell apoptosis by targetingSLC7A11. FEBS Lett 2011, 585:1363-1367. 10.1016/j.febslet.2011.04.018, 21510944.
12. Schmedtje JF, Ji YS, Liu WL, DuBois RN, Runge MS. Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells. J Biol Chem 1997, 272:601-608. 10.1074/jbc.272.1.601, 8995303.
13. Liu XH, Kirschenbaum A, Yao S, Stearns ME, Holland JF, Claffey K, Levine AC. Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line. Clin Exp Metastasis 1999, 17:687-694. 10.1023/A:1006728119549, 10919714.
14. Dossus L, Kaaks R, Canzian F, Albanes D, Berndt SI, Boeing H, Buring J, Chanock SJ, Clavel-Chapelon F, Feigelson HS, Gaziano JM, Giovannucci E, Gonzalez C, Haiman CA, Hallmans G, Hankinson SE, Hayes RB, Henderson BE, Hoover RN, Hunter DJ, Khaw KT, Kolonel LN, Kraft P, Ma J, Le Marchand L, Lund E, Peeters PH, Stampfer M, Stram DO, Thomas G. PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3). Carcinogenesis 2010, 31:455-461. 10.1093/carcin/bgp307, 2832545, 19965896.
15. Langsenlehner U, Yazdani-Biuki B, Eder T, Renner W, Wascher TC, Paulweber B, Weitzer W, Samonigg H, Krippl P. The cyclooxygenase-2 (PTGS2) 8473T>C polymorphism is associated with breast cancer risk. Clin Cancer Res 2006, 12:1392-1394. 10.1158/1078-0432.CCR-05-2055, 16489098.
16. Festa-Vasconcellos JS, Piranda DN, Amaral LM, Indio-do-Brasil V, Koifman S, Vianna-Jorge R. Polymorphisms in cycloxygenase-2 gene and breast cancer prognosis: association between PTGS2 haplotypes and histopathological features. Breast Cancer Res Treat 2012, 132:251-258. 10.1007/s10549-011-1828-0, 22037828.
17. Chakrabarty A, Tranguch S, Daikoku T, Jensen K, Furneaux H, Dey SK. MicroRNA regulation of cyclooxygenase-2 during embryo implantation. Proc Natl Acad Sci USA 2007, 104:15144-15149. 10.1073/pnas.0705917104, 1986627, 17848513.
18. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Ménard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M, Croce CM. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005, 65:7065-7070. 10.1158/0008-5472.CAN-05-1783, 16103053.
19. Yan LX, Huang XF, Shao Q, Huang MY, Deng L, Wu QL, Zeng YX, Shao JY. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 2008, 14:2348-2360. 10.1261/rna.1034808, 2578865, 18812439.
20. Ji Q, Hao X, Meng Y, Zhang M, Desano J, Fan D, Xu L. Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumor spheres. BMC Cancer 2008, 8:266. 10.1186/1471-2407-8-266, 2564978, 18803879.
21. Nagel R, le Sage C, Diosdado B, van der Waal M, Oude Vrielink JA, Bolijn A, Meijer GA, Agami R. Regulation of the adenomatous polyposiscoli gene by the miR-135 family in colorectal cancer. Cancer Res 2008, 68:5795-5802. 10.1158/0008-5472.CAN-08-0951, 18632633.
22. Liu W, Gong YH, Chao TF, Peng XZ, Yuan JG, Ma ZY, Jia G, Zhao JZ. Identification of differentially expressed microRNAs by microarray: a possible role for microRNAs gene in medulloblastomas. Chin Med J (Engl) 2009, 122:2405-2411.
23. Wu N, Zhao X, Liu M, Liu H, Yao W, Zhang Y, Cao S, Lin X. Role of microRNA-26b in glioma development and its mediated regulation on EphA2. PLoS One 2011, 6:e16264. 10.1371/journal.pone.0016264, 3021542, 21264258.
24. Zhu Y, Lu Y, Zhang Q, Liu JJ, Li TJ, Yang JR, Zeng C, Zhuang SM. MicroRNA-26a/b and their host genes cooperate to inhibit the G1/S transition by activating the pRb protein. Nucleic Acids Res 2012, 40:4615-4625. 10.1093/nar/gkr1278, 3378857, 22210897.
25. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, Lao KQ, Livak KJ, Guegler KJ. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005, 33:e179. 10.1093/nar/gni178, 1292995, 16314309.
26. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using Real-time quantitative PCR and the 2-ΔΔct method. Methods 2001, 25:402-408. 10.1006/meth.2001.1262, 11846609.